$140m Cash Boost For Leyden Labs Anti-Flu Nasal Spray
PanFlu Could Provide 'Protection At The Gate'
Executive Summary
The Dutch biotech has signed off a sizeable series B fundraising to take its intranasal products to fight current and future viral outbreaks into the clinic.